Literature DB >> 22395679

Limb-saving medicines sought to prevent amputations.

Cassandra Willyard.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22395679     DOI： 10.1038/nm0312-328

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.

Authors:  Mark A Creager; Jeffrey W Olin; Jill J F Belch; Gregory L Moneta; Timothy D Henry; Sanjay Rajagopalan; Brian H Annex; William R Hiatt
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

2.  Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.

Authors:  Jill Belch; William R Hiatt; Iris Baumgartner; I Vickie Driver; Sigrid Nikol; Lars Norgren; Eric Van Belle
Journal:  Lancet       Date:  2011-05-28       Impact factor: 79.321

3.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

Authors:  J M Isner; A Pieczek; R Schainfeld; R Blair; L Haley; T Asahara; K Rosenfield; S Razvi; K Walsh; J F Symes
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

4.  Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008.

Authors:  Yanfeng Li; Nilka Ríos Burrows; Edward W Gregg; Ann Albright; Linda S Geiss
Journal:  Diabetes Care       Date:  2012-02       Impact factor: 19.112
  4 in total
  8 in total

Review 1.  Gene therapy for Mucopolysaccharidoses.

Authors:  Kazuki Sawamoto; Hui-Hsuan Chen; Carlos J Alméciga-Díaz; Robert W Mason; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-12-26       Impact factor: 4.797

Review 2.  Promoting Limb Salvage through Multi-Disciplinary Care of the Diabetic Patient.

Authors:  Nichol L Salvo; Mark D Walsh; Luke P Brewster
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

3.  Dystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview.

Authors:  Dongsheng Duan
Journal:  Hum Gene Ther Clin Dev       Date:  2016-03       Impact factor: 5.032

4.  Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.

Authors:  Tatiana Chadid; Andrew Morris; Alexandra Surowiec; Scott Robinson; Maiko Sasaki; Jacques Galipeau; Brian P Pollack; Luke P Brewster
Journal:  J Vasc Surg       Date:  2018-08-10       Impact factor: 4.268

5.  The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis.

Authors:  Samuel T Hourigan; Emma L Solly; Victoria A Nankivell; Anisyah Ridiandries; Benjamin M Weimann; Rodney Henriquez; Edward R Tepper; Jennifer Q J Zhang; Tania Tsatralis; Zoe E Clayton; Laura Z Vanags; Stacy Robertson; Stephen J Nicholls; Martin K C Ng; Christina A Bursill; Joanne T M Tan
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

6.  Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Hector Barbosa; Adriana M Montaño; Luis A Barrera; Tsutomu Shimada; Eriko Yasuda; William G Mackenzie; Robert W Mason; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii
Journal:  Expert Opin Orphan Drugs       Date:  2013-10-01       Impact factor: 0.694

7.  Hydrogen Sulfide Improves Angiogenesis by Regulating the Transcription of pri-miR-126 in Diabetic Endothelial Cells.

Authors:  Wenlong Xue; Qingqing Zhang; Ying Chen; Yichun Zhu
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

8.  Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression.

Authors:  Jongsu Woo; Seong-Ho Bae; Bokyoung Kim; Jin Sil Park; Subin Jung; Minhyung Lee; Yong-Hee Kim; Donghoon Choi
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.